5-HT₂C

5-HT₂C is a serotonin receptor subtype found almost entirely within the central nervous system. While most serotonin receptors are distributed across the brain, gut, and blood, 5-HT₂C is concentrated in the choroid plexus, limbic structures, and cortex — making it a distinctly brain-specific target within the 5-HT₂ receptor family.

Its two most established roles are regulating appetite and acting as a brake on dopamine release. Because dopamine governs reward, motivation, and mood, this regulatory function gives 5-HT₂C an outsized influence on how the brain responds to food, stress, and psychoactive substances.

How it works · its role

5-HT₂C belongs to the Gq-coupled family of G protein-coupled receptors. When serotonin — or a drug acting in its place — binds to it, the receptor triggers intracellular signalling cascades that generally dampen nearby neuronal activity. The clearest downstream effect is on dopamine: 5-HT₂C activation reduces dopamine release in circuits tied to motivation and reward, while blocking the receptor allows dopamine to rise.

The receptor is also unusual in undergoing RNA editing — a post-transcriptional process that alters which amino acids are built into the final protein. This produces several receptor isoforms with subtly different sensitivities, a level of molecular complexity that is rare among serotonin receptors and that appears to vary between brain regions.

Relevance to substances & effects

Classic psychedelics such as psilocin and LSD bind to multiple serotonin subtypes, and 5-HT₂C is among them. The 5-HT₂A receptor is considered the primary driver of their characteristic perceptual effects, but activity at 5-HT₂C is thought to contribute to the mood shifts and anxiety modulation that can accompany a psychedelic experience.

Many psychiatric medications engage 5-HT₂C as part of a broader receptor profile. Several atypical antipsychotics and some antidepressants — mirtazapine being a clear example — block the receptor. This disinhibits dopamine release, which may support mood, but also promotes appetite and weight gain, a frequently reported side effect of 5-HT₂C antagonism.

Conversely, activating 5-HT₂C suppresses appetite, which attracted interest from obesity pharmacology. One drug targeting this mechanism reached clinical approval before being withdrawn for unrelated safety concerns — illustrating that the receptor sits at a meaningful and practically consequential intersection of mood, metabolism, and reward.